Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines and therapeutics into fridge free thermostable products.
Stablepharma Ltd has raised $2.6M in total funding. The most recent round was Grant. The last funding was announced in February 2025.
Stablepharma Ltd's investors include SFC Capital, European Innovation Council, Innovate UK, Ascension Ventures, EISMEA.
Stablepharma Ltd is headquartered in Bath, United Kingdom.
Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines and therapeutics into fridge free thermostable products.
Stablepharma Ltd is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stablepharma Ltd — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/stablepharma-ltd. Accessed September 29, 2026.
VCBacked. (2025). Stablepharma Ltd — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/stablepharma-ltd
{{cite web |title=Stablepharma Ltd — Funding & Investors |url=https://www.vcbacked.co/company/stablepharma-ltd |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated